Table 2. First-line chemotherapy regimens.
|
Patients (N=56) |
||
|---|---|---|
| Regimens | No. | % |
| BEPa | 37 | 66 |
| BOMP-EPI | 16 | 29 |
| EP | 2 | 4 |
| Other platinum based | 1 | 1 |
| High doseb | 7 | 13 |
BEP=etoposide, cisplatin, bleomycin, EP=etoposide, cisplatin, BOMP-EPI=bleomycin, vincristine, methotrexate, cisplatin/etoposide, ifosfamide, cisplatin.
a
Includes one patient nonassessable for response.
b
Immediately after conventional induction chemotherapy, seven poor-risk patients (IGCCC) received high-dose chemotherapy as consolidation treatment.